CA
BIO icon

Clearstead Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Clearstead Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$125K Buy
425
+14
+3% +$3.97K ﹤0.01% 1222
2026
Q1 		$115K Buy
411
+408
+13,600% +$118K ﹤0.01% 1111
2025
Q4 		$909 Buy
+3
New +$936 ﹤0.01% 2236
2025
Q2 		– Sell
-3
Closed -$731 – 2747
2025
Q1 		$731 Sell
3
-66
-96% -$19.9K ﹤0.01% 2027
2024
Q4 		$22.7K Sell
69
-133
-66% -$45.1K ﹤0.01% 1345
2024
Q3 		$67.6K Hold
202
– – ﹤0.01% 1134
2024
Q2 		$55.2K Buy
202
+74
+58% +$21.5K ﹤0.01% 1140
2024
Q1 		$36.5K Buy
128
+18
+16% +$5.92K ﹤0.01% 836
2023
Q4 		$35.5K Sell
110
-10
-8% -$3.13K ﹤0.01% 824
2023
Q3 		$43K Sell
120
-67
-36% -$25.9K ﹤0.01% 738
2023
Q2 		$70.9K Buy
187
+67
+56% +$27.3K ﹤0.01% 656
2023
Q1 		$57.5K Buy
+120
New +$56.2K ﹤0.01% 632
2022
Q2 		– Sell
-20
Closed -$11K – 1285
2022
Q1 		$11K Buy
+20
New +$12.1K ﹤0.01% 971
2021
Q3 		– Sell
-3
Closed -$2K – 1292
2021
Q2 		$2K Buy
+3
New +$1.83K ﹤0.01% 1022
2021
Q1 		– Sell
-22
Closed -$13K – 1116
2020
Q4 		$13K Hold
22
– – ﹤0.01% 682
2020
Q3 		$11K Hold
22
– – ﹤0.01% 650
2020
Q2 		$10K Hold
22
– – ﹤0.01% 600
2020
Q1 		$8K Buy
+22
New +$8.09K ﹤0.01% 590

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Clearstead Advisors's BIO Position: Q2 2026 in Review

Clearstead Advisors increased its Bio-Rad Laboratories Class A (BIO) stake by 3.4% in Q2 2026, buying an estimated $3.97K and bringing the position to 425 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Clearstead Advisors first reported a position in BIO in Q1 2020 and has held it in 18 quarters since. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Clearstead Advisors held 425 shares of Bio-Rad Laboratories Class A worth $125K as of Q2 2026.
  • Clearstead Advisors bought 14 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $3.97K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1222 holding.
  • Clearstead Advisors first reported a position in Bio-Rad Laboratories Class A in Q1 2020 and has held it in 18 quarters since.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.